Concomitant Use of Statins in Tocilizumab-Treated Patients with Rheumatoid Arthritis: A Post Hoc Analysis

INTRODUCTION: Patients with rheumatoid arthritis (RA) have decreased survival because of increased cardiovascular risk compared with the general population, and treatment with tocilizumab (TCZ) has been shown to increase lipid levels; however, the relationship between lipids and cardiovascular risk...

Descripción completa

Detalles Bibliográficos
Autores principales: Soubrier, Martin, Pei, Jinglan, Durand, Frédérick, Gullestad, Lars, John, Ani
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5443718/
https://www.ncbi.nlm.nih.gov/pubmed/27900570
http://dx.doi.org/10.1007/s40744-016-0049-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5443718/
https://www.ncbi.nlm.nih.gov/pubmed/27900570
http://dx.doi.org/10.1007/s40744-016-0049-8

Ejemplares similares